AVALON HOLDINGS CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data AVALON HOLDINGS CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	61.4	55.8	62.2	68.4	58.7	70.4	81.2	80.9	83.8	83.5
Cost of revenue	50.5							66.7	66.6	67.2
Gross profit	10.8							14.2	17.2	16.3
Selling, general and administrative	8.2	8.45	9	9.43	8.67	9.88	10.1	10.2	10.2	10.5
Operating income	-0.19	-0.27	-2.7	0.13	0.12	0.56	0.35	0.11	3.08	2.03
Interest expense	0.38	0.7	0.68	0.84	1.21	1.16	1.46	2.1	2.04	2.04
Other non-operating income	0.28	0.28	0.28	0.33	0.34	0.37	0.23	0	0.01	0
Pre-tax income	-0.28	-0.69	-3.09	-0.38	0.05	1.74	-0.89	-1.99	1.04	-0.02
Income tax	0.13	0.12	0.17	0.16	0.1	0.09	0.09	0.06	0.09	0.08
Net income to minority interests	-0.34	-0.51	-2.11	-0.08	-0.06	-0.32	-0.4	-0.27	-0.37	-0.42
Net income	-0.07	-0.31	-1.14	-0.46	0.01	1.97	-0.58	-1.78	1.32	0.32
EBITDA	2.63	2.73	0.18	2.66	3.03	3.67	3.83	3.94	6.98	5.83
EPS, basic	-0.02	-0.08	-0.30	-0.12	0.00	0.51	-0.15	-0.46	0.34	0.08
EPS, diluted	-0.02	-0.08	-0.30	-0.12	0.00	0.50	-0.15	-0.46	0.34	0.08
Shares, basic (weighted)	3.8	3.8	3.81	3.88	3.88	3.9	3.9	3.9	3.9	3.9
Shares, diluted (weighted)	3.8	3.8	3.81	3.88	3.88	3.93	3.9	3.9	3.9	3.9

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	2.3	1.03	1.41	1.45	4.21	3.25	1.62	1.19	2.8	4.11
Receivables	11.3	9.91	12.2	12	8.74	9.93	11.1	9.5	8.6	9.82
Inventory	0.77	0.85	0.82	0.81	0.91	1.11	1.46	1.66	1.56	1.56
Other current assets	0.04	0.03	0.03	0.02	0.08	0.11	0.11	0.01	0.02	0.02
Total current assets	14.9	12.9	15.6	15.6	15.3	16	16.1	14	14.6	17
Property, plant and equipment	44	43.2	42.5	49	51.3	53.3	56.8	56.6	55.6	54
Lease right-of-use assets				1.47	1.73	1.6	1.39	1.27	1.38	1.38
Other non-current assets	0.06	0.06	0.03	0.04	0.04	0.04	0.04	0.04	0.03	0.03
Total assets	67.9	65.4	64.8	79.2	78	78	89.8	88	86.2	87.4
Accounts payable	9.39	7.83	10.5	11.7	9.1	10.2	11	9.66	7.12	7.98
Accrued liabilities	0.68	0.74	0.87	0.96	0.81	0.8	0.99	1.28	1.06	1.24
Deferred revenue	2.72	2.72	2.9	3.15	3.2	3.36	3.64	3.44	3.52	3.53
Short-term debt	0.52	0.55	0.58	1.02	1.59	1.13	0.5	0.54	0.58	0.61
Total current liabilities	14.7	13.1	16.3	19	17.2	18	18.9	17.9	15.5	16.8
Long-term debt	11.3	10.7	10.2	21.6	21.9	19.4	29.8	29.2	28.6	28
Lease liabilities				0.95	1.2	1.06	0.96	0.84	1.02	1.02
Total liabilities	26.5	24.8	27.3	42.2	41	39.1	51.6	51.9	49.1	50.4
Total debt	11.8	11.3	10.7	22.6	23.5	20.5	30.3	29.8	29.2	28.6
Paid-in capital	59	59	59.1	59.1	59.2	59.2	59.2	59.2	59.2	59.2
Retained earnings	-20.3	-20.6	-21.7	-22.2	-22.1	-20.2	-20.8	-22.5	-21.2	-20.9
Shareholders' equity	38.7	38.4	37.5	37	37.1	39.1	38.5	36.7	38	38.4
Minority interests	2.64	2.13	0.01	-0.07	-0.13	-0.09	-0.35	-0.62	-0.98	-1.4
Total equity	41.4	40.6	37.5	37	37	39	38.1	36.1	37.1	37
Total liabilities and equity	67.9	65.4	64.8	79.2	78	78	89.8	88	86.2	87.4

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	-0.41	-0.82	-3.26	-0.54	-0.05	1.65	-0.98	-2.04	0.95	-0.1
Depreciation and amortization	2.82	3	2.88	2.52	2.91	3.11	3.48	3.83	3.91	3.8
Stock-based compensation	0.03	0.01	0.01	0.01	0.01	0.01	0	0	0
Deferred income tax					0	0	0	0	-0.02	-0.01
Change in receivables	-1.89	0.87	-2.33	0.16	3.23	-1.23	1.23	1.57	0.84	-1.4
Change in inventory	0.06	-0.08	0.03	0.01	-0.1	-0.2	0.36	-0.2	0.1	0
Change in payables	1.24	-1.56	1.97	0.68	-2.77	0.8	0.66	-1.36	-2.75	0.83
Cash from operations	2.59	1.25	3.06	3.15	2.57	2.36	2.26	2.36	3.37	3.78
Capital expenditures	-3	-1.79	-3.14	-7.16	-4.55	-4.42	-6.39	-3.9	-2.25	-1.73
Acquisitions				-0.09
Cash from investing	-3	-1.79	-4.38	-7.2	-4.51	-4.42	-6.39	-3.9	-2.25	-1.73
Debt issued	12					0	31	0
Debt repaid		-0.54	-0.57	-14.6	-1.06	-1.11	-21	-0.56	-0.6	-0.64
Stock issued			0.17		0.04	0
Cash from financing	0.9	-0.81	-0.62	10.8	1.4	-1.09	11.2	0.94	-0.82	-0.97
Net change in cash	0.49	-1.35	-1.94	6.72	-0.54	-3.15	7.1	-0.6	0.31	1.08
Free cash flow	-0.41	-0.54	-0.08	-4.01	-1.98	-2.06	-4.13	-1.54	1.12	2.06
Interest paid	0.36	0.68	0.65	0.79	1.16	1.13	1.31	2.01	2.18	1.99
Income taxes paid	0.05	0.14	0.11	0.15	0.15	0.07	0.1	0.2	0.05	0.09

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $2.59 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	20.5%	Gross profit / revenue.
Operating margin	3.6%	Operating income / revenue.
EBITDA margin	7.9%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	1.2%	Pre-tax income / revenue.
Net margin	1.4%	Net income / revenue.
FCF margin	1.5%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	4.1%	Cash from operations / revenue.
Effective tax rate	9.8%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	3.1%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	1.4%	Net income / average total assets.
Return on invested capital (ROIC)	4.5%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	12.6%	Selling, general and administrative expense / revenue.
Capex / revenue	2.6%	Capital expenditures / revenue.
D&A / revenue	4.3%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-0.3%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	1.0%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	7.3%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-5.2%	Gross profit vs the same period a year earlier. Only from a positive base.
Operating income growth, 1y	-34.1%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	80.0%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	74.8%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-16.5%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	15.0%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	14.0%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-75.6%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 5y	87.1%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-76.5%	EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	12.2%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	18.8%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	8.0%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	83.6%	Free cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y	0.8%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-0.1%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	0.7%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	1.4%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-0.9%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	2.3%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.0%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.0%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.1%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.02x	Current assets / current liabilities.
Quick ratio	0.83x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.26x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.75x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	32.3%	Total debt / total assets.
Liabilities / assets	58.4%	Total liabilities / total assets.
Net debt	$23.5M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	3.48x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	1.50x	Operating income / interest expense.
Working capital	$380.0K	Current assets - current liabilities.
Tangible book value	$38.0M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.98x	Revenue / average total assets.
Fixed asset turnover	1.61x	Revenue / average property, plant and equipment.
Inventory turnover	37.1x	Cost of revenue / average inventory.
Days inventory	10 days	365 x average inventory / cost of revenue.
Receivables turnover	8.42x	Revenue / average receivables.
Days sales outstanding	43 days	365 x average receivables / revenue.
Days payables	35 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	18 days	Days inventory + days sales outstanding - days payables.
FCF conversion	106.6%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	63.4%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.31	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$22.00	Revenue / diluted weighted shares.
FCF per share	$0.33	Free cash flow / diluted weighted shares.
Operating cash flow per share	$0.89	Cash from operations / diluted weighted shares.
Book value per share	$9.75	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$9.75	Tangible book value / shares outstanding.
Cash per share	$1.23	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$10.1M	Share price x shares outstanding.
Enterprise value	$33.6M	Market cap + total debt - cash - short-term investments.
P/E	8.44x	Market cap / net income. Only when net income is positive.
P/S	0.12x	Market cap / revenue.
P/B	0.27x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	0.27x	Market cap / tangible book value, when positive.
P/FCF	7.92x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	2.89x	Market cap / cash from operations, when positive.
EV/Sales	0.39x	Enterprise value / revenue.
EV/EBIT	11.0x	Enterprise value / operating income, when both are positive.
EV/EBITDA	4.97x	Enterprise value / EBITDA, when both are positive.
EV/FCF	26.4x	Enterprise value / free cash flow, when both are positive.
FCF yield	12.6%	Free cash flow / market cap.
Earnings yield	11.9%	Net income / market cap (the inverse of P/E).

What was AVALON HOLDINGS CORP's revenue in fiscal 2025?

AVALON HOLDINGS CORP reported revenue of $83.5M for fiscal 2025, 0.3% lower than the year before.

Was AVALON HOLDINGS CORP profitable in fiscal 2025?

Yes. Net income was $321.0K, a net margin of 0.4%.

How much free cash flow did AVALON HOLDINGS CORP generate in fiscal 2025?

Cash from operations of $3.8M minus capital expenditures of $1.7M left free cash flow of $2.1M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to AVALON HOLDINGS CORP